February 17, 2009 -
David Evans -
... analogue reverse transcriptase inhibitor (NRTI) called amdoxovir; and bevirimat, a maturation inhibitor. All have made it through ...
http://www.aidsmeds.com/articles/hiv_drugs_development_2042_16129.shtml
January 22, 2009 -
January 22, 2009 Myriad Acquires Rights to Develop Bevirimat Salt Lake City based Myriad Pharmaceuticals has purchased the rights to develop and eventually sell bevirimat, a promising HIV maturation inhibitor currently in Phase ... company will receive a $7 million payment for bevirimat, allowing it to focus on other antiretrovirals (ARVs ... is required for the virus to become infectious. Bevirimat, a derivative of the Chinese herb Syzigium claviflorum ... According to Panacos, 15 small clinical trials with bevirimat involving nearly 650 HIV-negative and HIV- ...
http://www.aidsmeds.com/articles/hiv_bevirimat_panacos_myriad_1667_15976.shtml
March 6, 2008 -
March 6, 2008 Bevirimat Success Hinges on HIV Mutations The experimental maturation inhibitor, Bevirimat (PA-457), is most effective in people whose ... Gag protein, announced the drug’s developer, Panacos.Bevirimat, which stops newly assembled viral particles from maturing ... that roughly 50 percent would likely respond to bevirimat.Testing for the polymorphisms could be accomplished by ... not yet announced what dose or formulation of bevirimat may be used in future studies.
http://www.aidsmeds.com/articles/bevirimat_hiv_aids_1667_14177.shtml
June 21, 2007 -
Tim Horn -
June 21, 2007 Panacos' Bevirimat Back on Track (AIDSmeds.com) by Tim Horn ... track with the development of its maturation inhibitor bevirimat (PA-457) in patients with HIV resistant to ... on to infect other cells in the body. Bevirimat, a derivative of a Chinese herb called Syzigium ... inhibitor to enter phase II clinical trials. Because bevirimat works differently than currently available HIV drugs, it ... were selected to receive a liquid formulation of bevirimat (25mg, 50mg, 100mg, or 200mg), or a ...
http://www.aidsmeds.com/articles/1667_12309.shtml
December 21, 2006 -
Tim Horn -
December 21, 2006 Maturation Inhibitor Bevirimat Hits Dosing Snag (AIDSmeds.com) by Tim Horn ... a Phase IIb study of its maturation inhibitor bevirimat (PA-457) in patients with HIV resistance to ... approved medications. While the unpublished data suggest that bevirimat has anti-HIV activity in this patient population, the blood concentrations of bevirimat – along with its effects on viral load ... on to infect other cells in the body. Bevirimat, a derivative of a Chinese herb called ...
http://www.aidsmeds.com/articles/1667_11050.shtml
November 20, 2009 PI Resistance Reduces Bevirimat Potency Some disturbing news for treatment-experienced patients holding out for Myriad Genetics maturation inhibitor bevirimat: According to a study published online November 18 ... to protease inhibitors (PIs) reduces the effectiveness of bevirimat in up to 45 percent of cases. Maturation ... of the virus to make it infectious reduce bevirimat s effectiveness in about 40 percent of people ... with HIV. There is another possible chink in bevirimat s armor. The drug attacks proteins in ...
http://www.poz.com/articles/hiv_bevirimat_resistance_761_17613.shtml
... special reports November 20, 2009 PI Resistance Reduces Bevirimat Potency November 19, 2009 Accelerated Aging of Blood ...
http://www.poz.com/special/index.shtml
... more news November 20, 2009 PI Resistance Reduces Bevirimat Potency November 19, 2009 Accelerated Aging of Blood ...
http://www.poz.com/usca2006/index.shtml
... More news November 20, 2009 PI Resistance Reduces Bevirimat Potency November 19, 2009 Accelerated Aging of Blood ...
http://www.poz.com/x.standard_two_column.shtml
... Living Hubs November 20, 2009 PI Resistance Reduces Bevirimat Potency November 19, 2009 Accelerated Aging of Blood ...
http://www.poz.com/index.old.shtml
